Free Trial

Premier (PINC) Stock Forecast & Price Target

Premier logo
$22.84 +0.42 (+1.87%)
(As of 11/22/2024 ET)

Premier - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Sell
0
Hold
9
Buy
0

Based on 9 Wall Street analysts who have issued ratings for Premier in the last 12 months, the stock has a consensus rating of "Hold." Out of the 9 analysts, 9 have given a hold rating for PINC.

Consensus Price Target

$21.36
-6.49% Downside
According to the 9 analysts' twelve-month price targets for Premier, the average price target is $21.36. The highest price target for PINC is $24.00, while the lowest price target for PINC is $19.00. The average price target represents a forecasted downside of -6.49% from the current price of $22.84.
Get the Latest News and Ratings for PINC and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Premier and its competitors.

Sign Up

PINC Analyst Ratings Over Time

TypeCurrent Forecast
11/26/23 to 11/25/24
1 Month Ago
10/27/23 to 10/26/24
3 Months Ago
8/28/23 to 8/27/24
1 Year Ago
11/26/22 to 11/26/23
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
0 Buy rating(s)
0 Buy rating(s)
0 Buy rating(s)
3 Buy rating(s)
Hold
9 Hold rating(s)
9 Hold rating(s)
9 Hold rating(s)
6 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
1 Sell rating(s)
Consensus Price Target$21.36$21.81$22.19$27.50
Forecasted Upside-6.49% Downside10.39% Upside12.11% Upside31.45% Upside
Consensus Rating
Hold
Hold
Hold
Hold

PINC Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

PINC Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Premier Stock vs. The Competition

TypePremierMedical CompaniesS&P 500
Consensus Rating Score
2.00
2.80
2.50
Consensus RatingHoldModerate BuyModerate Buy
Predicted Upside-6.49% Downside27,006.27% Upside7.66% Upside
News Sentiment Rating
Positive News

See Recent PINC News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
11/6/2024Canaccord Genuity Group
1 of 5 stars
 Boost TargetHold ➝ Hold$19.00 ➝ $21.00-8.58%
11/6/2024Barclays
3 of 5 stars
 Boost TargetEqual Weight ➝ Equal Weight$20.00 ➝ $24.00+4.48%
11/6/2024Robert W. Baird
2 of 5 stars
 Boost TargetNeutral ➝ Neutral$19.00 ➝ $20.00-11.78%
9/9/2024JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetNeutral ➝ Neutral$21.00 ➝ $19.00-3.70%
8/26/2024Benchmark
Subscribe to MarketBeat All Access for the recommendation accuracy rating
W. Sutherland
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Hold
5/8/2024Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetNeutral ➝ Neutral$24.00 ➝ $22.00+12.42%
2/26/2024Leerink Partnrs
Subscribe to MarketBeat All Access for the recommendation accuracy rating
S. Davis
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingMarket Perform
2/26/2024Leerink Partners
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageMarket Perform$22.50+4.07%
8/24/2023Credit Suisse Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetNeutral ➝ Neutral$33.00 ➝ $25.00+14.21%
8/23/2023UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetNeutral ➝ Neutral$29.00 ➝ $26.00+8.11%
8/23/2023Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetUnderperform ➝ Underperform$31.00 ➝ $26.00+8.11%
5/2/2023Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeOutperform ➝ Market Perform

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Monday at 05:52 AM ET.


PINC Forecast - Frequently Asked Questions

According to the research reports of 9 Wall Street equities research analysts, the average twelve-month stock price forecast for Premier is $21.36, with a high forecast of $24.00 and a low forecast of $19.00.

9 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Premier in the last twelve months. There are currently 9 hold ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" PINC shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in PINC, but not buy additional shares or sell existing shares.

According to analysts, Premier's stock has a predicted downside of -6.49% based on their 12-month stock forecasts.

Premier has been rated by research analysts at Barclays, Canaccord Genuity Group, JPMorgan Chase & Co., and Robert W. Baird in the past 90 days.

Analysts like Premier less than other "medical" companies. The consensus rating for Premier is Hold while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how PINC compares to other companies.


This page (NASDAQ:PINC) was last updated on 11/25/2024 by MarketBeat.com Staff
From Our Partners